Reports Q4 revenue $2.39B, consensus $2.47B. “Oscar reported positive full year 2024 results, capping the strongest year of financial ...

The insurer also reported notable ACA growth for this year, though membership could tick back down through the second quarter ...

Health insurance provider Elevance Health (NYSE:EVH) in Q4 CY2024, with sales up 6.6% year on year to $45.44 billion. Its non ...

Q4 2024 Earnings Call Transcript January 30, 2025 Quest Diagnostics Incorporated beats earnings expectations. Reported EPS is ...

Mizuho Securities analyst Ann Hynes has maintained their bullish stance on DGX stock, giving a Buy rating yesterday.Invest with Confidence: ...

Jack Meehan; Analyst; Nephron Research Erin Wright; Analyst; Morgan Stanley ...

During Q4 2024, global stocks were pressured by investor concerns about economic growth and persistent inflation in some regions & despite potential for further interest rate cuts in 2025.

CEO Jim Davis reported a nearly 15% revenue growth for Q4, including 5% organic growth, and close to 7% revenue growth for the full year, supported by eight acquisitions. He highlighted the Advanced ...